[8-K] Vistagen Therapeutics, Inc. Reports Material Event
Filing Impact
Filing Sentiment
Form Type
8-K
Rhea-AI Filing Summary
Vistagen Therapeutics, Inc. approved retention awards in the form of stock option grants for all employees. Key executives, including the CEO, CLO, Chief Corporate Development Officer, COO, and CFO, each received options to purchase up to 75,000 shares of common stock.
The options were granted on April 7, 2026 under the Amended and Restated 2019 Omnibus Equity Incentive Plan at an exercise price of $0.5358 per share. Twenty-five percent vests six months after the grant date, with additional 25% installments every six months until fully vested after two years.
Positive
- None.
Negative
- None.
8-K Event Classification
Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers
1 item
Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers
Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Key Figures
Executive option grant size: 75,000 options
Exercise price: $0.5358 per share
Grant date: April 7, 2026
+4 more
7 metrics
Executive option grant size
75,000 options
Per named executive under the 2019 Omnibus Equity Incentive Plan
Exercise price
$0.5358 per share
Stock options granted on April 7, 2026
Grant date
April 7, 2026
Date options were issued as retention awards
Initial vesting portion
25% of options
Vests six months after the grant date
Subsequent vesting installments
25% every six months
After initial vesting until fully vested
Full vesting period
2 years
Options fully vest on the two-year anniversary of grant
Number of named executives
5 executives
Senior officers receiving 75,000 options each
Key Terms
retention awards, stock option grant, exercise price, vest, +1 more
5 terms
retention awards financial
"approved of retention awards in the form of a stock option grant"
stock option grant financial
"approved of retention awards in the form of a stock option grant (the “Options”)"
exercise price financial
"have an exercise price of $0.5358 per share"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vest financial
"25% of the Options will vest six months after the Grant Date"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
2019 Omnibus Equity Incentive Plan financial
"under the Company’s Amended and Restated 2019 Omnibus Equity Incentive Plan"
